MétaCan
Menu
Back to cohort

Association between Leflunomide and Pulmonary Hypertension

2021· article· en· W3121159740 on OpenAlexaff
Thomas Lacoste-Palasset, Marie‐Camille Chaumais, Jason Weatherald, Laurent Savale, Xavier Jaïs, Laura Price, Charles Khouri, Sophie Bulifon, Andrei Seferian, Mitja Jevnikar, Athénaïs Boucly, Grégoire Manaud, Stefana Pancic, Céline Chabanne, Kaïs Ahmad, Mathilde Volpato, Nicolas Favrolt, Anne Guillaumot, Delphine Horeau-Langlard, Grégoire Prévôt, Pierre Fesler, Laurent Bertoletti, Martine Reynaud‐Gaubert, Nicolas Lamblin, David Launay, Gérald Simonneau, Olivier Sitbon, Frédéric Perros, Marc Humbert, David Montani

Bibliographic record

VenueAnnals of the American Thoracic Society · 2021
Typearticle
Languageen
FieldMedicine
TopicPulmonary Hypertension Research and Treatments
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsMedicineLeflunomidePulmonary hypertensionAssociation (psychology)MEDLINEInternal medicineCardiologyIntensive care medicineRheumatoid arthritis

Abstract

fetched live from OpenAlex

Abstract Rationale Pulmonary hypertension (PH) has been described in patients treated with leflunomide. Objectives To assess the association between leflunomide and PH. Methods We identified incident cases of PH in patients treated with leflunomide from the French PH Registry and through the pharmacoVIGIlAnce in Pulmonary ArTerial Hypertension (VIGIAPATH) program between September 1999 to December 2019. PH etiology, clinical, functional, radiologic, and hemodynamic characteristics were reviewed at baseline and follow-up. A pharmacovigilance disproportionality analysis using the World Health Organization’s global database was conducted. We then investigated the effect of leflunomide on human pulmonary endothelial cells. Data are expressed as median (min–max). Results Twenty-eight patients treated with leflunomide before PH diagnosis was identified. A total of 21 (75%) had another risk factor for PH and 2 had two risk factors. The median time between leflunomide initiation and PH diagnosis was 32 months (1–120). Right heart catheterization confirmed precapillary PH with a cardiac index of 2.37 L⋅min−1 ⋅m−2 (1.19–3.1) and elevated pulmonary vascular resistance at 9.63 Wood Units (3.6–22.1) without nitric oxide reversibility. Five patients (17.9%) had no other risk factor for PH besides exposure to leflunomide. No significant hemodynamic improvement was observed after leflunomide withdrawal. The pharmacovigilance disproportionality analysis using the World Health Organization’s database revealed a significant overrepresentation of leflunomide among reported pulmonary arterial hypertension–adverse drug reactions. In vitro studies showed the dose-dependent toxicity of leflunomide on human pulmonary endothelial cells. Conclusions PH associated with leflunomide is rare and usually associated with other risk factors. The pharmacovigilance analysis suggests an association reinforced by experimental data.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.109
GPT teacher head0.393
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueAnnals of the American Thoracic SocietySame topicPulmonary Hypertension Research and TreatmentsFrench-language works237,207